Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001279569-07-001590
Filing Date
2007-11-05
Accepted
2007-11-02 20:14:50
Documents
5
Period of Report
2007-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A aspreva8ka18330.htm 8-K/A 31448
2 PRESS RELEASE DATED OCTOBER 31, 2007 ex991.htm EX-99.1 264767
3 TRANSCRIPT OF CONFERENCE CALL HELD OCTOBER 31, 2007 ex992.htm EX-99.2 71976
4 COVER cover.jpg GRAPHIC 57752
5 LOGO asprevalogo.jpg GRAPHIC 4624
  Complete submission text file 0001279569-07-001590.txt   455932
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

EIN.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51169 | Film No.: 071212124
SIC: 2834 Pharmaceutical Preparations